Abraham Susan C, Cruz-Correa Marcia, Argani Pedram, Furth Emma E, Hruban Ralph H, Boitnott John K
Department of Pathology, Hilton 11, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Am J Surg Pathol. 2003 Apr;27(4):441-51. doi: 10.1097/00000478-200304000-00003.
Lymphoplasmacytic sclerosing pancreatitis (LPSP) represents a distinctive form of chronic pancreatitis characterized by diffuse fibroinflammatory infiltrates that can involve both the pancreatic ducts and acinar parenchyma. Several cases of inflammatory infiltrates within the gallbladder have been reported in association with LPSP, but the spectrum of gallbladder pathology in patients with LPSP has not been systematically reviewed. Many patients with LPSP have distal CBD fibrosis, strictures, and inflammation, features that overlap somewhat with primary sclerosing cholangitis (PSC). In PSC, a pattern of gallbladder pathology termed "diffuse acalculous lymphoplasmacytic chronic cholecystitis" has been previously described as showing a triad of diffuse, mucosal-based, plasma cell-rich inflammatory infiltrates. We studied 20 gallbladders from patients with LPSP and compared them with 20 gallbladders in PSC, 20 gallbladders with chronic cholelithiasis, and 10 gallbladders from patients with benign (non-LPSP) pancreatic disease. The following features were evaluated: degree and composition of mucosal inflammation and deep (mural) inflammation, lymphoid nodules, metaplasia, dysplasia/neoplasia, fibrosis, muscular hypertrophy, Rokitansky-Aschoff sinuses, and cholesterolosis. The majority (60%) of gallbladders in LPSP contained moderate or marked inflammatory infiltrates and lymphoid nodules, frequencies similar to PSC but significantly higher than in chronic cholelithiasis and benign non-LPSP pancreatic disease. LPSP gallbladders received the highest scores for deep inflammation of all groups, and 35% of LPSP gallbladders showed transmural chronic cholecystitis. Overall, "diffuse lymphoplasmacytic chronic cholecystitis" was present in 50% of PSC cases and 25% of LPSP cases, but in only 5% of chronic cholelithiasis and none of non-LPSP benign pancreatic disease. Mucosal inflammation in LPSP gallbladders correlated significantly with the presence of inflammation in the extrapancreatic portion of the CBD. These findings suggest that inflammatory pathology of the gallbladder is frequently associated with LPSP and that it is part of the spectrum of biliary tract disease in these patients, rather than a simple reflection of the pancreatitis itself.
淋巴浆细胞性硬化性胰腺炎(LPSP)是一种独特的慢性胰腺炎形式,其特征为弥漫性纤维炎性浸润,可累及胰腺导管和腺泡实质。已有数例胆囊内炎性浸润与LPSP相关的报道,但LPSP患者胆囊病理的全貌尚未得到系统综述。许多LPSP患者存在肝外胆管远端纤维化、狭窄和炎症,这些特征与原发性硬化性胆管炎(PSC)有一定重叠。在PSC中,一种称为“弥漫性无结石性淋巴浆细胞性慢性胆囊炎”的胆囊病理模式先前已被描述为表现出弥漫性、以黏膜为基础、富含浆细胞的炎性浸润三联征。我们研究了20例LPSP患者的胆囊,并将其与20例PSC患者的胆囊、20例慢性胆石症患者的胆囊以及10例良性(非LPSP)胰腺疾病患者的胆囊进行比较。评估了以下特征:黏膜炎症和深部(壁层)炎症的程度及组成、淋巴小结、化生、发育异常/肿瘤形成、纤维化、肌肉肥大、罗-阿窦以及胆固醇沉着症。LPSP患者的大多数(60%)胆囊含有中度或显著的炎性浸润和淋巴小结,其发生率与PSC相似,但显著高于慢性胆石症和良性非LPSP胰腺疾病患者。LPSP胆囊在所有组中深部炎症得分最高,35%的LPSP胆囊表现为透壁性慢性胆囊炎。总体而言,“弥漫性淋巴浆细胞性慢性胆囊炎”在50%的PSC病例和25%的LPSP病例中存在,但在仅5%的慢性胆石症病例中存在,而在非LPSP良性胰腺疾病病例中则无。LPSP胆囊的黏膜炎症与肝外胆管部分的炎症存在显著相关性。这些发现表明,胆囊的炎性病理常与LPSP相关,并且是这些患者胆道疾病谱的一部分,而非仅仅是胰腺炎本身的反映。